Acomplia Rimonabant, Zimulti News For 2009

Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009

Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]


Diet Pill Acomplia Now Widely Available in Mexican Border Pharmacies

Diet drug Acomplia (rimonabant) , which seems at best months away from sale in the United States, is now widely available in pharmacies just across the Mexican border.
Readers increasingly are sending us reports on their experiences purchasing the highly anticipated diet pill in Mexican towns just across [...]


Global Sales of Acomplia (Rimonabant, Zimulti) Edge up to $50 Million in 2nd Quarter

Net sales of diet drug Acomplia (Rimonabant, Zimulti) edged up to almost $50 million (32 million Euros) in the second quarter of 2008, according to French pharmaceutical gians Sanofi-aventis.
This marked the strongest quarter for Acomplia (Rimonabant, Zimulti) since its launch two years ago, and was aided [...]


2d Generic Version of Diet Pill Rimonabant (Acomplia / Zimulti) Launched in India

ond Acomplia (rimonabant) Indian pharmaceutical company, Torrent Pharmaceuticals Ltd., has announced that it also is selling a generic version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Rimoslim.
The news, which attracted little attention in the West, occurred almost simultaneously with last week’s announcement by Zydus [...]


Acomplia (Rimonabant) Shows Promise

UK biopharmaceutical company Vernalis on Sept. 14th announced that a diet drug it is developing similar to Acomplia (rimonabant) , V24343, had produced “striking weight loss” in patients in two small phase I clinical trials, with one patient losing 24 pounds in just over two weeks.
The [...]


Quitting smoking rimonabant

Quitting smoking rimonabantQuitting smoking is difficult, and the fact that quitting smoking often leads to unhealthy weight gain is often a justification for people to delay their attempts to break free from their habit.
Smoking is the leading preventable cause of death in the world today, and if [...]


Sanofi Allowed to Inform Patients Taking Acomplia That It Aids Blood Sugar Control

The European Commission has decided to let Sanofi-Aventis inform patients taking diet drug Acomplia (rimonabant) that the pill may also help in diabetic blood sugar control, but that does not mean it is approved to be prescribed as a diabetes drug.
The announcement, which ratified an [...]


Diet Drug Acomplia Found to Up Risk of Anxiety and Depression in Heart Study

Diet drug rimonabant (Acomplia / Zimulti ) produced disappointing results in slowing progression of coronary artery disease in patients and it significantly raised the risk of anxiety and depression, according to a report in the April 2 issue of the Journal of the American Medical Association.
[...]


News Acomplia Zimulti